These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 18384884)

  • 1. Normal development and function of dendritic cells in mice lacking IDO-1 expression.
    de Faudeur G; de Trez C; Muraille E; Leo O
    Immunol Lett; 2008 Jun; 118(1):21-9. PubMed ID: 18384884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constitutive expression of IDO by dendritic cells of mesenteric lymph nodes: functional involvement of the CTLA-4/B7 and CCL22/CCR4 interactions.
    Onodera T; Jang MH; Guo Z; Yamasaki M; Hirata T; Bai Z; Tsuji NM; Nagakubo D; Yoshie O; Sakaguchi S; Takikawa O; Miyasaka M
    J Immunol; 2009 Nov; 183(9):5608-14. PubMed ID: 19843945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-autonomous control of interferon type I expression by indoleamine 2,3-dioxygenase in regulatory CD19+ dendritic cells.
    Manlapat AK; Kahler DJ; Chandler PR; Munn DH; Mellor AL
    Eur J Immunol; 2007 Apr; 37(4):1064-71. PubMed ID: 17343295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunoregulatory role of IDO-producing human dendritic cells revisited.
    Terness P; Chuang JJ; Opelz G
    Trends Immunol; 2006 Feb; 27(2):68-73. PubMed ID: 16406698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IDO expands human CD4+CD25high regulatory T cells by promoting maturation of LPS-treated dendritic cells.
    Hill M; Tanguy-Royer S; Royer P; Chauveau C; Asghar K; Tesson L; Lavainne F; Rémy S; Brion R; Hubert FX; Heslan M; Rimbert M; Berthelot L; Moffett JR; Josien R; Grégoire M; Anegon I
    Eur J Immunol; 2007 Nov; 37(11):3054-62. PubMed ID: 17948274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are indoleamine-2,3-dioxygenase producing human dendritic cells a tool for suppression of allogeneic T-cell responses?
    Löb S; Ebner S; Wagner S; Weinreich J; Schäfer R; Königsrainer A
    Transplantation; 2007 Feb; 83(4):468-73. PubMed ID: 17318080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transient upregulation of indoleamine 2,3-dioxygenase in dendritic cells by human chorionic gonadotropin downregulates autoimmune diabetes.
    Ueno A; Cho S; Cheng L; Wang J; Hou S; Nakano H; Santamaria P; Yang Y
    Diabetes; 2007 Jun; 56(6):1686-93. PubMed ID: 17360980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandin E2 is a key factor for monocyte-derived dendritic cell maturation: enhanced T cell stimulatory capacity despite IDO.
    Krause P; Singer E; Darley PI; Klebensberger J; Groettrup M; Legler DF
    J Leukoc Biol; 2007 Nov; 82(5):1106-14. PubMed ID: 17698915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of indoleamine 2,3-dioxygenase protects mice against lipopolysaccharide-induced endotoxin shock.
    Jung ID; Lee MG; Chang JH; Lee JS; Jeong YI; Lee CM; Park WS; Han J; Seo SK; Lee SY; Park YM
    J Immunol; 2009 Mar; 182(5):3146-54. PubMed ID: 19234212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-affinity uptake of kynurenine and nitric oxide-mediated inhibition of indoleamine 2,3-dioxygenase in bone marrow-derived myeloid dendritic cells.
    Hara T; Ogasawara N; Akimoto H; Takikawa O; Hiramatsu R; Kawabe T; Isobe K; Nagase F
    Immunol Lett; 2008 Feb; 116(1):95-102. PubMed ID: 18179826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Echinococcus granulosus recombinant antigen B induced IDO expression in mouse bone marrow-derived dendritic cells in vitro].
    Shan JY; Ji WZ; Tursun T; Li L; Zhang CS; Lin RY; Wen H
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2011 Apr; 29(2):111-6. PubMed ID: 21826895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel cancer therapy by skin delivery of indoleamine 2,3-dioxygenase siRNA.
    Yen MC; Lin CC; Chen YL; Huang SS; Yang HJ; Chang CP; Lei HY; Lai MD
    Clin Cancer Res; 2009 Jan; 15(2):641-9. PubMed ID: 19147770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steady state dendritic cells with forced IDO expression induce skin allograft tolerance by upregulation of regulatory T cells.
    Yu G; Fang M; Gong M; Liu L; Zhong J; Feng W; Xiong P; Wang CY; Gong F
    Transpl Immunol; 2008 Jan; 18(3):208-19. PubMed ID: 18047928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indoleamine 2,3-dioxygenase expression and functional activity in dendritic cells exposed to cholera toxin.
    Slavica L; Nurkkala-Karlsson M; Karlson T; Ingelsten M; Nyström J; Eriksson K
    Scand J Immunol; 2012 Aug; 76(2):113-22. PubMed ID: 22519828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COX-2 and PGE2 signaling is essential for the regulation of IDO expression by curcumin in murine bone marrow-derived dendritic cells.
    Jung ID; Jeong YI; Lee CM; Noh KT; Jeong SK; Chun SH; Choi OH; Park WS; Han J; Shin YK; Kim HW; Yun CH; Park YM
    Int Immunopharmacol; 2010 Jul; 10(7):760-8. PubMed ID: 20399909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A potential role for indoleamine 2,3-dioxygenase (IDO) in Rhodococcus equi infection.
    Heller MC; Drew CP; Jackson KA; Griffey S; Watson JL
    Vet Immunol Immunopathol; 2010 Dec; 138(3):174-82. PubMed ID: 20739070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of allogeneic T-cell responses by dendritic cells expressing transduced indoleamine 2,3-dioxygenase.
    Funeshima N; Fujino M; Kitazawa Y; Hara Y; Hara Y; Hayakawa K; Okuyama T; Kimura H; Li XK
    J Gene Med; 2005 May; 7(5):565-75. PubMed ID: 15543532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut CD103+ dendritic cells express indoleamine 2,3-dioxygenase which influences T regulatory/T effector cell balance and oral tolerance induction.
    Matteoli G; Mazzini E; Iliev ID; Mileti E; Fallarino F; Puccetti P; Chieppa M; Rescigno M
    Gut; 2010 May; 59(5):595-604. PubMed ID: 20427394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic cell maturation with poly(I:C)-based versus PGE2-based cytokine combinations results in differential functional characteristics relevant to clinical application.
    Möller I; Michel K; Frech N; Burger M; Pfeifer D; Frommolt P; Veelken H; Thomas-Kaskel AK
    J Immunother; 2008 Jun; 31(5):506-19. PubMed ID: 18463533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolerogenic dendritic cells transferring hyporesponsiveness and synergizing T regulatory cells in transplant tolerance.
    Li M; Zhang X; Zheng X; Lian D; Zhang ZX; Sun H; Suzuki M; Vladau C; Huang X; Xia X; Zhong R; Garcia B; Min WP
    Int Immunol; 2008 Feb; 20(2):285-93. PubMed ID: 18182381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.